What is the role of epsilon-ACA in minimizing blood loss during liver transplantation?

Updated: Apr 19, 2019
  • Author: Vanessa A Olcese, MD, PhD; Chief Editor: Ron Shapiro, MD  more...
  • Print


Epsilon-aminocaproic acid (epsilon-ACA) has been used intraoperatively to inhibit fibrinolysis. It has been found effective for decreasing blood requirements in some studies but not in others. In a prospective, double-blinded, placebo-controlled, randomized study by Dalmau et al, prophylactic epsilon-ACA did not reduce intraoperative total PRBC transfusion during OLT; however, tranexamic acid did significantly reduce intraoperative transfusion requirements. [28]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!